Symbol Name ID |
Il2
interleukin 2 MGI:96548 |
* | Aspects of the system are reported to show a normal phenotype. |
! | Indicates phenotype varies with strain background. |
Darker colors indicate more annotations |
Human Phenotypes | Decreased circulating IgA level |
Decreased circulating IgG level |
Decreased circulating IgG2 level |
Defective B cell differentiation |
Abnormal B cell count |
Decreased proportion of CD4-positive helper T cells |
T lymphocytopenia |
Lymphopenia |
Leukopenia |
Hemophagocytosis |
Leukemia |
Acute lymphoblastic leukemia |
Sinusitis |
Stomatitis |
Allergic rhinitis |
Conjunctivitis |
Pericarditis |
Lymphadenopathy |
Hypoplasia of the thymus |
Hepatosplenomegaly |
Gastrointestinal inflammation |
Recurrent gastroenteritis |
Peritoneal abscess |
Acute hepatitis |
Chronic hepatitis |
Subacute progressive viral hepatitis |
Iridocyclitis |
Inflammatory abnormality of the eye |
Epididymitis |
Lupus nephritis |
Nephritis |
Abnormality of the immune system |
Fasciitis |
Inflammatory abnormality of the skin |
Eczematoid dermatitis |
Atopic dermatitis |
Erythema nodosum |
Recurrent skin infections |
Discoid lupus rash |
Maculopapular exanthema |
Malar rash |
Myositis |
Pneumonia |
Serositis |
Decreased circulating complement C3 concentration |
Decreased circulating complement C4 concentration |
Autoimmunity |
Anti-citrullinated protein antibody positivity |
Antineutrophil antibody positivity |
Perinuclear antineutrophil antibody positivity |
Antinuclear antibody positivity |
Anti-dsDNA antibody positivity |
Anti-La/SS-B antibody positivity |
Anti-Sm antibody positivity |
Anti-U1 ribonucleoprotein antibody positivity |
Antiphospholipid antibody positivity |
Platelet antibody positive |
Rheumatoid factor positive |
Systemic lupus erythematosus |
Asthma |
Recurrent infections |
Recurrent lower respiratory tract infections |
Recurrent bronchitis |
Disease(s) Associated with IL2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
alopecia areata | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asthma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ataxia telangiectasia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
atopic dermatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
autoimmune thrombocytopenic purpura | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Behcet's disease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
graft-versus-host disease | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
hepatocellular carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pancreatic cancer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
rheumatoid arthritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
systemic lupus erythematosus | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
type 1 diabetes mellitus |
Mouse Phenotypes | immune system phenotype |
heart inflammation |
increased B cell proliferation |
abnormal T cell proliferation |
decreased T cell proliferation |
increased T cell proliferation |
decreased splenocyte proliferation |
large intestinal inflammation |
colitis |
salivary gland inflammation |
abnormal thymocyte activation |
lacrimal gland inflammation |
pancreas inflammation |
enlarged spleen |
spleen hyperplasia |
abnormal class switch recombination |
increased pro-B cell number |
abnormal T-helper 1 cell differentiation |
decreased double-negative T cell number |
increased double-negative T cell number |
decreased double-positive T cell number |
increased susceptibility to autoimmune hemolytic anemia |
abnormal lymphocyte cell number |
increased germinal center B cell number |
increased plasma cell number |
increased pre-B cell number |
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number |
increased T-helper 17 cell number |
increased CD4-positive, alpha-beta T cell number |
increased CD8-positive, alpha-beta T cell number |
decreased regulatory T cell number |
increased regulatory T cell number |
increased T cell number |
increased activated T cell number |
increased single-positive T cell number |
abnormal lymphocyte morphology |
abnormal CD8 positive, alpha-beta intraepithelial T cell morphology |
abnormal gamma-delta intraepithelial T cell morphology |
abnormal spleen morphology |
increased spleen red pulp amount |
increased splenocyte number |
abnormal lymphocyte physiology |
increased IgA level |
increased IgE level |
increased IgG1 level |
increased IgG2a level |
increased IgG2b level |
increased IgG level |
impaired natural killer cell mediated cytotoxicity |
abnormal CD4-positive, alpha-beta T cell physiology |
abnormal cytotoxic T cell physiology |
decreased cytotoxic T cell cytolysis |
abnormal T cell activation |
abnormal regulatory T cell physiology |
abnormal circulating cytokine level |
decreased circulating interferon-gamma level |
decreased circulating interleukin-13 level |
decreased circulating interleukin-17 level |
increased circulating interleukin-17 level |
decreased circulating interleukin-4 level |
enlarged mesenteric lymph nodes |
enlarged lymph nodes |
lymph node hyperplasia |
abnormal level of surface class II molecules |
abnormal susceptibility to autoimmune disorder |
increased susceptibility to autoimmune disorder |
increased susceptibility to autoimmune diabetes |
increased inflammatory response |
liver inflammation |
lung inflammation |
abnormal susceptibility to Riboviria infection |
abnormal response to transplant |
increased length of allograft survival |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il2m1/Il2m1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il2tm1.1Flv/Il2tm1.1Flv | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il2tm1Hor/Il2tm1Hor | * | ! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il2tm1Hor/Il2+ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Il2tm1.1Kasm/Il2tm1.1Kasm Ndor1Tg(UBC-cre/ERT2)1Ejb/? (conditional) |
* |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|